Mark W Sawicki
CIK 1848218 · Chief Scientific Officer · last filed 2026-03-25
Mark W Sawicki is a Chief Scientific Officer who has filed 15 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing shows the insider sold $11.0K of CYRX on Mar 25, 2026. Across all open-market trades the lifetime net is −$5.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.50M
1
15
-$5.66M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CYRX | Chief Scientific Officer | 102,356 | $14.62 | $1.50M | -$5.66M | 15 | 2026-03-25 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-25 | CYRX | Sell (S) | −1,341 | -$11.0K | EDGAR |
| 2026-03-17 | CYRX | Mixed | +19,610 | -$25.9K | EDGAR |
| 2025-03-26 | CYRX | Sell (S) | −1,349 | -$9.4K | EDGAR |
| 2025-03-18 | CYRX | Mixed | +6,908 | -$13.2K | EDGAR |
| 2025-03-11 | CYRX | Mixed | +1,084 | -$7.7K | EDGAR |
| 2024-03-26 | CYRX | Sell (S) | −1,367 | -$24.0K | EDGAR |
| 2024-03-19 | CYRX | Mixed | +5,686 | -$43.4K | EDGAR |
| 2023-09-13 | CYRX | Exer (M) | +1,000 | $12.8K | EDGAR |
| 2023-03-24 | CYRX | Grant (A) | +10,455 | $0 | EDGAR |
| 2023-03-17 | CYRX | Sell (S) | −1,362 | -$28.3K | EDGAR |